2757470-18-9

2757470-18-9 structure
2757470-18-9 structure
  • Name: Ensitrelvir fumarate
  • Chemical Name: Ensitrelvir fumarate
  • CAS Number: 2757470-18-9
  • Molecular Formula: C26H21ClF3N9O6
  • Molecular Weight: 647.95
  • Catalog: Signaling Pathways Anti-infection SARS-CoV
  • Create Date: 2022-04-06 13:30:46
  • Modify Date: 2026-07-01 15:29:23
  • Ensitrelvir (S-217622) fumarate is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM)[1][2].

Name Ensitrelvir fumarate
Synonyms Ensitrelvir fumate
S-217622
Ensitrelvir fumate(S-217622)
(E) - 6 - ((6-chloro-2-methyl-2h-indazole-5-yl) imino) - 3 - ((1-methyl-1h-1,2,4-triazol-3-yl) methyl) - 1 - (2,4,5-trifluorobenzyl) - 1,3,5-triazinane-2,4-dione fumate
S-217622-002-C4H4O4
S-217622 fumate
Ensitrelvir Fumic Acid
1,3,5-Triazine-2,4(1H,3H)-dione, 6-[(6-chloro-2-methyl-2H-indazol-5-yl)imino]dihydro-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-, (6E)-, (2E)-2-butenedioate (1:1)
Ensitrelvir Fumate (S-217622 Fumate)
(E)-6-((6-Chloro-2-methyl-2H-indazol-5-yl)imino)-3-((1-methyl-1H-1,2,4-triazol-3-yl)methyl)-1-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4-dione fumate
RMA-43
Description Ensitrelvir (S-217622) fumarate is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM)[1][2].
Related Catalog
In Vitro In a cytopathic effect (cpe)-inhibition assay of SARS-CoV-2 infected VeroE6/TMPRSS2 cells, Ensitrelvir fumarate shows the EC50 values are approximately 0.4 μM for both wild-type virus and Alpha, Beta, Gamma and Delta variants. EC50 values for SARS-CoV and MERS-CoV were 0.21 and 1.4 μM respectively[1].
In Vivo Ensitrelvir fumarate dose-dependently inhibits intrapulmonary replication of SARS-CoV-2 in mice[2].
References

[1]. McKimm-Breschkin JL, et al. COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference. Antiviral Res. 2022;197:105227.

[2]. Yuto Unoh, et al. Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19. bioRxiv 2022.01.26.477782.

Molecular Formula C26H21ClF3N9O6
Molecular Weight 647.95
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.